NDC 45802-147 – Cetirizine hydrochloride and Pseudoephedrine hydrochloride

Cetirizine Hydrochloride 5 mg/1; Pseudoephedrine Hydrochloride 120 mg/1 · Tablet, Film Coated, Extended Release · Oral

Human Otc Drug

Product NDC45802-147

Product details

Brand name
Cetirizine hydrochloride and Pseudoephedrine hydrochloride
Generic name
Cetirizine hydrochloride, Pseudoephedrine hydrochloride
Labeler
Padagis Israel Pharmaceuticals Ltd
Dosage form
Tablet, Film Coated, Extended Release
Route
Oral
Marketing category
ANDA · ANDA210719
Marketed since
March 31, 2020
Listing expires
December 31, 2026
Pharmacologic class
Histamine-1 Receptor Antagonist; alpha-Adrenergic Agonist

Active ingredients

Uses, dosage, side effects and warnings for Cetirizine hydrochloride and Pseudoephedrine hydrochloride →

Package NDC codes (2)

Package NDCDescriptionSince
45802-147-5312 BLISTER PACK in 1 CARTON (45802-147-53) / 1 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACKMar 31, 2020
45802-147-6224 BLISTER PACK in 1 CARTON (45802-147-62) / 1 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACKMar 31, 2020

Other Cetirizine hydrochloride and Pseudoephedrine hydrochloride products